Crocs, Emergent Bio, Macy's and More Friday Afternoon Analyst Calls

Investing

Published: February 19, 2021 12:37 pm

With the trading day more than halfway over, the broad markets were sliding into the weekend. The Dow Jones industrial average hit a new all-time high in Friday’s session, while the S&P 500 and Nasdaq each posted all-time highs earlier in the week.

24/7 Wall St. is looking at some big analyst calls that we have seen so far on Friday. We have included the most recent analyst call on each stock, as well as a recent trading history and the general consensus among analysts.

For those that might have missed it, 24/7 Wall St. had an earlier round of analyst calls on Friday that included Applied Materials, Clorox, Kraft Heinz, Roku, Under Armour and more.

CNAFinancial Corp. (NYSE: CNA) was upgraded to Outperform from Market Perform and its price target was increased to $52 from $41 at Keefe Bruyette. Shares traded below $44 on Friday. The 52-week trading range is $25.18 to $47.97.

Crocs Inc. (NASDAQ: CROX) was reiterated as Buy and its price target was raised to $92 from $87 at Pivotal Research Group. Shares were trading above $82. The stock has traded within a 52-week range of $8.40 to $84.09. It has a consensus price target of $84.75.

Emergent BioSolutions Inc. (NYSE: EBS) was downgraded at Chardan Capital Markets to Neutral from Buy with a $112 price target. The stock was trading near $107, in a 52-week trading range of $46.37 to $137.61. The consensus price target is $113.00.

Macy’s Inc. (NYSE: M) was reiterated by Telsey Advisory Group with a Market Perform rating and its price target was raised to $14 from $10. The shares traded around $15. The 52-week range is $4.38 to $22.30, and analysts have a consensus price target of $9.50.

Montauk Renewables Inc. (NASDAQ: MNTK) was initiated with a Buy rating and a $17.50 price target at Roth Capital. The stock traded around $14 on Friday, in a 52-week range of $9.65 to $14.93.

Molina Healthcare Inc. (NYSE: MOH) was resumed at Barclays with an Overweight rating and a $260 price target. Shares traded near $220 on Friday. The 52-week range is $102.85 to $246.72, and the consensus price target is $244.64.

MRC Global Inc. (NYSE: MRC) was downgraded at JPMorgan from Overweight to Neutral with a $7 price target. The consensus price target is $9.13. Shares traded around $8 on Friday, in the 52-week range of $3.31 to $9.97.

Newmark Group Inc. (NASDAQ: NMRK) was upgraded at Piper Sandler to Overweight from Neutral, and its price target was raised to $12 from $7.50. The stock traded over $9 on Friday. The 52-week trading range is $2.49 to $12.04. Analysts have a consensus price target of $8.92.

NeoPhotonics Corp. (NYSE: NPTN) was resumed at Piper Sandler with a Neutral rating and a $13 price target. Early Friday, the stock traded above $12. The 52-week range is $4.65 to $14.14, and the consensus price target is $12.06.

24/7 Wall St.
Why 5 Buy-Rated Energy Stocks May Have Much Higher Upside Potential

With the economy reopening and travel returning, as well as the recent spike in the price of oil, one top analyst sees these five Buy-rated energy stocks as perhaps having much higher upside potential.

Love it or hate it? What do Americans think about bitcoin?

Travel Cards Are Getting Too Good To Ignore (sponsored)

Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.

We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.

It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.

We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.